Ustekinumab and TNF-inhibitors in the treatment of moderate to severe psoriasis

被引：0
|
作者：
Garcia Lopez, Isabel [1 ]
Herranz Alonso, Ana [1 ]
Rodriguez Gonzalez, Carmen Guadelupe [1 ]
Castillo Romera, Isabel [1 ]
Pernia Lopez, Sagrario [1 ]
Sanjurjo Saez, M. [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Dept Pharm, ES-28007 Madrid, Spain
来源：
EJHP PRACTICE | 2011年 / 17卷 / 01期
关键词：
INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; PHASE-III; EFFICACY; PLACEBO; SAFETY; THERAPY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：46 / 50
页数：5
相关论文
共 50 条
  • [1] Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series
    Lund, Tamara
    Thomsen, Simon Francis
    [J]. DERMATOLOGIC THERAPY, 2017, 30 (03)
  • [2] Ustekinumab for the treatment of moderate to severe psoriasis
    Gospodarevskaya, E.
    Picot, J.
    Cooper, K.
    Loveman, E.
    Takeda, A.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 61 - 66
  • [3] Efficacy of Ustekinumab in the Treatment of Moderate-Severe Psoriasis
    Jimenez-Puya, R.
    Moreno, J. C.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 : 16 - 24
  • [4] COST EFFECTIVENESS OF TREATMENT WITH ETANERCEPT OR USTEKINUMAB FOR MODERATE TO SEVERE PSORIASIS
    Villacorta, R.
    Hay, J.
    Messali, A.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A103 - A103
  • [5] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Croxtall, Jamie D.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2012, 13 (02) : 135 - 137
  • [6] Mixed treatment comparison of infliximab with ustekinumab in patients with moderate to severe psoriasis
    Fan, T.
    Bennett, H.
    Smith, N.
    Marin, M.
    Shuvayu, S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E38 - E39
  • [7] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Aguirre, A.
    Guerrero, E.
    Hernandez, N.
    Coronell, S.
    Argote, A. C.
    Giraldo, C., V
    Ojeda, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A211 - A211
  • [8] Spotlight on Ustekinumab in Moderate To Severe Plaque Psoriasis
    Jamie D. Croxtall
    [J]. American Journal of Clinical Dermatology, 2012, 13 : 135 - 137
  • [9] Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
    Chan, Wai Sze Agnes
    Wong, Yisheng
    Oon, Hazel Hwee Boon
    Theng, Colin Thiam Seng
    Chong, Wei-Sheng
    [J]. SINGAPORE MEDICAL JOURNAL, 2023, 64 (07) : 434 - 438
  • [10] COST-UTILITY OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN COLOMBIA
    Ojeda, C.
    Hernandez, N.
    Giraldo, C., V
    Argote, A. C.
    Coronell, S.
    Roa, M.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A124 - A124
12345